Aligos Therapeutics
ALGS
ALGS
52 hedge funds and large institutions have $30.4M invested in Aligos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 17
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$139K | |
| 2 | +$129K | |
| 3 | +$85K | |
| 4 |
NM
Newtyn Management
New York
|
+$41.7K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.1K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$190K | |
| 3 | -$145K | |
| 4 |
D.E. Shaw & Co
New York
|
-$137K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$93.5K |